Selective intracellular vaporisation of antibody-conjugated phase-change nano-droplets in vitro

While chemotherapy is a major mode of cancer therapeutics, its efficacy is limited by systemic toxicities and drug resistance. Recent advances in nanomedicine provide the opportunity to reduce systemic toxicities. However, drug resistance remains a major challenge in cancer treatment research. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishijima, A., Minamihata, K., Yamaguchi, S., Yamahira, S., Ichikawa, R., Kobayashi, E., Iijima, M., Shibasaki, Y., Azuma, T., Nagamune, T., Sakuma, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363066/
https://www.ncbi.nlm.nih.gov/pubmed/28333127
http://dx.doi.org/10.1038/srep44077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363066/
https://www.ncbi.nlm.nih.gov/pubmed/28333127
http://dx.doi.org/10.1038/srep44077

Ejemplares similares